Drug treatments for spasticity

Annals of Physical and Rehabilitation Medicine

Volumn 52, Issue 10, 2009, Pages 746-756

  Yelnik, A P ^a   Simon, O ^a   Bensmail, D ^b   Chaleat Valayer, E ^c   Decq, P ^d   Dehail, P ^e   Quentin, V ^f   Marque, P ^g   Parratte, B ^h   Pellas, F ⁱ   Rousseaux, M ^j   Trocello, J M ^k   Uzzan, M ^l   Dumarcet, N ^l  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b RAYMOND POINCARÉ HOSPITAL   (France)

^c CMPR Les Massues   (France)

^d HENRI MONDOR HOSPITAL   (France)

^e Ctr Geriatrie Ctr Hosp Univ B   (France)

^f Hopital de Saint Maurice   (France)

^g CHU RANGUEIL   (France)

^h UNIVERSITY HOSPITAL OF BESANÇON   (France)

ⁱ DEPARTMENT OF NEUROLOGY   (France)

^j LILLE UNIVERSITY HOSPITAL   (France)

^k HÔPITAL SAINT ANTOINE   (France)

^l AFSSAPS   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BACLOFEN; BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN A; BOTULINUM TOXIN B; DIAZEPAM; PHENOL; TIZANIDINE;

ARTICLE; CEREBRAL PALSY; CLINICAL PRACTICE; COMORBIDITY; DRUG APPROVAL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MARKETING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; ELECTROMYOGRAM; HUMAN; MULTIPLE SCLEROSIS; NONHUMAN; RECOMMENDED DRUG DOSE; RISK FACTOR; SPASTICITY; SPINE INJURY; STROKE;

ADMINISTRATION, ORAL; ADULT; ALCOHOLS; ALGORITHMS; ANTI-DYSKINESIA AGENTS; BACLOFEN; BOTULINUM TOXINS; CHILD; CLONIDINE; DECISION TREES; HUMANS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SPINAL; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY; PATIENT SELECTION; PHENOL; SAFETY; SCLEROSING SOLUTIONS; TREATMENT OUTCOME;

EID: 72449171473     PISSN: 18770657     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rehab.2009.09.005     Document Type: Article

References (0)